Meiling Ji

1.8k total citations
50 papers, 1.1k citations indexed

About

Meiling Ji is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Meiling Ji has authored 50 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 19 papers in Molecular Biology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Meiling Ji's work include Colorectal Cancer Treatments and Studies (9 papers), Ferroptosis and cancer prognosis (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Meiling Ji is often cited by papers focused on Colorectal Cancer Treatments and Studies (9 papers), Ferroptosis and cancer prognosis (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Meiling Ji collaborates with scholars based in China, United States and France. Meiling Ji's co-authors include Guodong He, Jianmin Xu, Ye Wei, Wenju Chang, Dexiang Zhu, Qingyang Feng, Li Ren, Liangliang Yang, Wentao Tang and Yihao Mao and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Oncogene.

In The Last Decade

Meiling Ji

50 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meiling Ji China 19 527 351 324 217 191 50 1.1k
Xiaohan Ren China 22 408 0.8× 266 0.8× 211 0.7× 370 1.7× 120 0.6× 52 972
Ying Jiao China 14 492 0.9× 229 0.7× 350 1.1× 95 0.4× 196 1.0× 30 1.1k
Qian Ma China 18 537 1.0× 284 0.8× 146 0.5× 235 1.1× 142 0.7× 85 1.2k
Giuseppe Lattanzio Italy 15 414 0.8× 121 0.3× 287 0.9× 141 0.6× 245 1.3× 35 1.2k
Srikanth Nagalla United States 14 634 1.2× 472 1.3× 233 0.7× 129 0.6× 178 0.9× 44 1.5k
Robin Park United States 18 268 0.5× 149 0.4× 435 1.3× 166 0.8× 123 0.6× 68 904
Verena von Bülow Germany 9 723 1.4× 320 0.9× 218 0.7× 69 0.3× 218 1.1× 13 1.2k
Jana Nekvindová Czechia 20 846 1.6× 672 1.9× 193 0.6× 158 0.7× 45 0.2× 48 1.4k

Countries citing papers authored by Meiling Ji

Since Specialization
Citations

This map shows the geographic impact of Meiling Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiling Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiling Ji more than expected).

Fields of papers citing papers by Meiling Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meiling Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiling Ji. The network helps show where Meiling Ji may publish in the future.

Co-authorship network of co-authors of Meiling Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Meiling Ji. A scholar is included among the top collaborators of Meiling Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meiling Ji. Meiling Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tang, Wentao, Yuqiu Xu, Wenju Chang, et al.. (2023). Apolipoprotein L3 enhances CD8+ T cell antitumor immunity of colorectal cancer by promoting LDHA-mediated ferroptosis. International Journal of Biological Sciences. 19(4). 1284–1298. 40 indexed citations
3.
Lv, Yang, Peng Zheng, Yihao Mao, et al.. (2023). Intratumor APOL3 delineates a distinctive immunogenic ferroptosis subset with prognosis prediction in colorectal cancer. Cancer Science. 115(1). 257–269. 7 indexed citations
4.
Li, Shuna, Qingqing Li, Meiling Ji, et al.. (2022). PHB3 regulates lateral root primordia formation via NO-mediated degradation of AUXIN/INDOLE-3-ACETIC ACID proteins. Journal of Experimental Botany. 73(12). 4034–4045. 19 indexed citations
5.
Xu, Yuqiu, Mei Feng, Dexiang Zhu, et al.. (2022). Tumor-infiltrated activated B cells suppress liver metastasis of colorectal cancers. Cell Reports. 40(9). 111295–111295. 44 indexed citations
6.
Liu, Yu, Wentao Tang, Li Ren, et al.. (2022). Activation of miR-500a-3p/CDK6 axis suppresses aerobic glycolysis and colorectal cancer progression. Journal of Translational Medicine. 20(1). 106–106. 11 indexed citations
7.
Zhang, Zhiyuan, Meiling Ji, Qi Wu, et al.. (2021). Molecular Classification Based on Prognostic and Cell Cycle-Associated Genes in Patients With Colon Cancer. Frontiers in Oncology. 11. 636591–636591. 10 indexed citations
8.
Liu, Yu, Wenju Chang, Wentao Tang, et al.. (2021). The Combination of Neoadjuvant Therapy and Surgical Resection: A Safe and Effective Treatment for Rectal Gastrointestinal Stromal Tumors. Cancer Management and Research. Volume 13. 4671–4678. 3 indexed citations
9.
Zhang, Zhiyuan, Meiling Ji, Yang Lv, et al.. (2020). A signature predicting relapse based on integrated analysis on relapse-associated alternative mRNA splicing in I–III rectal cancer. Genomics. 112(5). 3274–3283. 9 indexed citations
10.
Jian, Mi, Li Ren, Guodong He, et al.. (2020). A novel patient-derived organoids-based xenografts model for preclinical drug response testing in patients with colorectal liver metastases. Journal of Translational Medicine. 18(1). 234–234. 60 indexed citations
11.
Feng, Qingyang, Wenju Chang, Yihao Mao, et al.. (2019). Tumor-associated Macrophages as Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients with Stage II Colon Cancer. Clinical Cancer Research. 25(13). 3896–3907. 104 indexed citations
12.
Ji, Meiling, Wenxiang Li, Guodong He, et al.. (2019). Zinc-α2-glycoprotein 1 promotes EMT in colorectal cancer by filamin A mediated focal adhesion pathway. Journal of Cancer. 10(22). 5557–5566. 18 indexed citations
13.
Lin, Qi, Jun Li, Dexiang Zhu, et al.. (2019). Aberrant Scinderin Expression Correlates With Liver Metastasis and Poor Prognosis in Colorectal Cancer. Frontiers in Pharmacology. 10. 1183–1183. 15 indexed citations
14.
Mao, Yihao, Qingyang Feng, Peng Zheng, et al.. (2018). Low tumor purity is associated with poor prognosis, heavy mutation burden, and intense immune phenotype in colon cancer. Cancer Management and Research. Volume 10. 3569–3577. 87 indexed citations
15.
Niu, Zhengchuan, Wentao Tang, Tianyu Liu, et al.. (2018). Cell-free DNA derived from cancer cells facilitates tumor malignancy through Toll-like receptor 9 signaling-triggered interleukin-8 secretion in colorectal cancer. Acta Biochimica et Biophysica Sinica. 50(10). 1007–1017. 24 indexed citations
16.
Zheng, Peng, Li Ren, Qingyang Feng, et al.. (2018). Differences in clinical characteristics and mutational pattern between synchronous and metachronous colorectal liver metastases. Cancer Management and Research. Volume 10. 2871–2881. 11 indexed citations
17.
Chang, Wenju, Lujun Song, Xiujuan Chang, et al.. (2016). Early activated hepatic stellate cell-derived paracrine molecules modulate acute liver injury and regeneration. Laboratory Investigation. 97(3). 318–328. 25 indexed citations
18.
Ji, Meiling, Binbin Wen, Li Liu, et al.. (2016). GOLDEN 2-LIKE Transcription Factors of Plants. Frontiers in Plant Science. 7. 1509–1509. 94 indexed citations
19.
Lin, Qi, Ye Wei, Yunshi Zhong, et al.. (2014). Aberrant expression of sphingosine-1-phosphate receptor 1 correlates with metachronous liver metastasis and poor prognosis in colorectal cancer. Tumor Biology. 35(10). 9743–9750. 13 indexed citations
20.
Ji, Meiling, Chenxi Shi, Wenli Li, et al.. (2013). FoxO regulates expression of ABCA6, an intracellular ATP-binding-cassette transporter responsive to cholesterol. The International Journal of Biochemistry & Cell Biology. 45(11). 2651–2659. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026